Literature DB >> 15973462

Genetic control of parasite clearance leads to resistance to Plasmodium berghei ANKA infection and confers immunity.

S Campino1, S Bagot, M-L Bergman, P Almeida, N Sepúlveda, S Pied, C Penha-Gonçalves, D Holmberg, P-A Cazenave.   

Abstract

Unprecedented cure after infection with the lethal Plasmodium berghei ANKA was observed in an F2 progeny generated by intercrossing the wild-derived WLA and the laboratory C57BL/6 mouse strains. Resistant mice were able to clear parasitaemia and establish immunity. The observed resistance was disclosed as a combinatorial effect of genetic factors derived from the two parental strains. Genetic mapping of survival time showed that the WLA allele at a locus on chromosome 1 (colocalizing with Berghei resistance 1 (Berr1), a locus associated with resistance to experimental cerebral malaria) increases the probability to resist early death. Also, the C57Bl/6 allele at a novel locus on chromosome 9 (Berr3) confers overall resistance to this lethal Plasmodium infection. This report underlines the value of using wild-derived mouse strains to identify novel genetic factors in the aetiology of disease phenotypes, and provides a unique model for studying parasite clearance and immunity associated with malaria.

Entities:  

Mesh:

Year:  2005        PMID: 15973462     DOI: 10.1038/sj.gene.6364219

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  14 in total

Review 1.  How malaria has affected the human genome and what human genetics can teach us about malaria.

Authors:  Dominic P Kwiatkowski
Journal:  Am J Hum Genet       Date:  2005-07-06       Impact factor: 11.025

Review 2.  Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.

Authors:  Sabrina Torre; David Langlais; Philippe Gros
Journal:  Mamm Genome       Date:  2018-06-19       Impact factor: 2.957

Review 3.  Host resistance to malaria: using mouse models to explore the host response.

Authors:  Rhea Longley; Clare Smith; Anny Fortin; Joanne Berghout; Brendan McMorran; Gaétan Burgio; Simon Foote; Philippe Gros
Journal:  Mamm Genome       Date:  2010-11-30       Impact factor: 2.957

Review 4.  Genetic mapping of determinants in drug resistance, virulence, disease susceptibility, and interaction of host-rodent malaria parasites.

Authors:  Xin-Zhuan Su; Jian Wu; Fangzheng Xu; Sittiporn Pattaradilokrat
Journal:  Parasitol Int       Date:  2022-08-01       Impact factor: 2.106

5.  Pretreatment with Cry1Ac protoxin modulates the immune response, and increases the survival of Plasmodium-infected CBA/Ca mice.

Authors:  Martha Legorreta-Herrera; Rodrigo Oviedo Meza; Leticia Moreno-Fierros
Journal:  J Biomed Biotechnol       Date:  2010-03-11

6.  Genome wide analysis of inbred mouse lines identifies a locus containing Ppar-gamma as contributing to enhanced malaria survival.

Authors:  Selina E R Bopp; Vandana Ramachandran; Kerstin Henson; Angelina Luzader; Merle Lindstrom; Muriel Spooner; Brian M Steffy; Oscar Suzuki; Chris Janse; Andrew P Waters; Yingyao Zhou; Tim Wiltshire; Elizabeth A Winzeler
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

7.  Characterization of cerebral malaria in the outbred Swiss Webster mouse infected by Plasmodium berghei ANKA.

Authors:  Yuri Chaves Martins; Mary Jane Smith; Marcelo Pelajo-Machado; Guilherme Loureiro Werneck; Henrique Leonel Lenzi; Claudio Tadeu Daniel-Ribeiro; Leonardo José de Moura Carvalho
Journal:  Int J Exp Pathol       Date:  2009-04       Impact factor: 1.925

8.  An N-ethyl-N-nitrosourea (ENU)-induced dominant negative mutation in the JAK3 kinase protects against cerebral malaria.

Authors:  Silayuv E Bongfen; Ian-Gael Rodrigue-Gervais; Joanne Berghout; Sabrina Torre; Pablo Cingolani; Sean A Wiltshire; Gabriel A Leiva-Torres; Louis Letourneau; Robert Sladek; Mathieu Blanchette; Mark Lathrop; Marcel A Behr; Samantha Gruenheid; Silvia M Vidal; Maya Saleh; Philippe Gros
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

9.  C5 deficiency and C5a or C5aR blockade protects against cerebral malaria.

Authors:  Samir N Patel; Joanne Berghout; Fiona E Lovegrove; Kodjo Ayi; Andrea Conroy; Lena Serghides; Gundula Min-oo; D Channe Gowda; J Vidya Sarma; Daniel Rittirsch; Peter A Ward; W Conrad Liles; Philippe Gros; Kevin C Kain
Journal:  J Exp Med       Date:  2008-04-21       Impact factor: 14.307

10.  Malaria liver stage susceptibility locus identified on mouse chromosome 17 by congenic mapping.

Authors:  Lígia Antunes Gonçalves; Paulo Almeida; Maria Manuel Mota; Carlos Penha-Gonçalves
Journal:  PLoS One       Date:  2008-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.